These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25894871)

  • 21. [SOD1 gene therapy delays ALS disease progression].
    Forsberg K; Karlsborg M; Salvesen L; Svenstrup K; Winroth I; Berntsson H; M Andersen P
    Lakartidningen; 2024 Apr; 121():. PubMed ID: 38666665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genetics of amyotrophic lateral sclerosis].
    Hübers A; Weishaupt JH; Ludolph AC
    Nervenarzt; 2013 Oct; 84(10):1213-9. PubMed ID: 24072096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
    Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR
    Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis.
    Kaur SJ; McKeown SR; Rashid S
    Gene; 2016 Feb; 577(2):109-18. PubMed ID: 26657039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study.
    Miller TM; Pestronk A; David W; Rothstein J; Simpson E; Appel SH; Andres PL; Mahoney K; Allred P; Alexander K; Ostrow LW; Schoenfeld D; Macklin EA; Norris DA; Manousakis G; Crisp M; Smith R; Bennett CF; Bishop KM; Cudkowicz ME
    Lancet Neurol; 2013 May; 12(5):435-42. PubMed ID: 23541756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.
    Giannoccaro MP; Bartoletti-Stella A; Piras S; Pession A; De Massis P; Oppi F; Stanzani-Maserati M; Pasini E; Baiardi S; Avoni P; Parchi P; Liguori R; Capellari S
    J Neurol; 2017 Jul; 264(7):1426-1433. PubMed ID: 28620717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Has gene therapy for ALS arrived?
    Miller TM; Cleveland DW
    Nat Med; 2003 Oct; 9(10):1256-7. PubMed ID: 14520369
    [No Abstract]   [Full Text] [Related]  

  • 28. Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS).
    Abati E; Bresolin N; Comi G; Corti S
    Expert Opin Ther Targets; 2020 Apr; 24(4):295-310. PubMed ID: 32125907
    [No Abstract]   [Full Text] [Related]  

  • 29. Gene Therapy for ALS-A Perspective.
    Cappella M; Ciotti C; Cohen-Tannoudji M; Biferi MG
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes.
    Millecamps S; Boillée S; Le Ber I; Seilhean D; Teyssou E; Giraudeau M; Moigneu C; Vandenberghe N; Danel-Brunaud V; Corcia P; Pradat PF; Le Forestier N; Lacomblez L; Bruneteau G; Camu W; Brice A; Cazeneuve C; Leguern E; Meininger V; Salachas F
    J Med Genet; 2012 Apr; 49(4):258-63. PubMed ID: 22499346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profiling tofersen as a treatment of superoxide dismutase 1 amyotrophic lateral sclerosis.
    Oliveira Santos M; de Carvalho M
    Expert Rev Neurother; 2024 Jun; 24(6):549-553. PubMed ID: 38758193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA Editing for Amyotrophic Lateral Sclerosis: Leading Off First Base.
    Cunningham TJ; Fisher E; Fratta P; Gilthorpe JD
    CRISPR J; 2020 Apr; 3(2):75-77. PubMed ID: 32315228
    [No Abstract]   [Full Text] [Related]  

  • 33. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.
    Lagier-Tourenne C; Baughn M; Rigo F; Sun S; Liu P; Li HR; Jiang J; Watt AT; Chun S; Katz M; Qiu J; Sun Y; Ling SC; Zhu Q; Polymenidou M; Drenner K; Artates JW; McAlonis-Downes M; Markmiller S; Hutt KR; Pizzo DP; Cady J; Harms MB; Baloh RH; Vandenberg SR; Yeo GW; Fu XD; Bennett CF; Cleveland DW; Ravits J
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):E4530-9. PubMed ID: 24170860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis.
    Nowicka N; Juranek J; Juranek JK; Wojtkiewicz J
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31141951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic studies of Russian patients with amyotrophic lateral sclerosis.
    Lysogorskaia EV; Abramycheva NY; Zakharova MN; Stepanova MS; Moroz AA; Rossokhin AV; Illarioshkin SN
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):135-41. PubMed ID: 26551617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extensive genetics of ALS: a population-based study in Italy.
    Chiò A; Calvo A; Mazzini L; Cantello R; Mora G; Moglia C; Corrado L; D'Alfonso S; Majounie E; Renton A; Pisano F; Ossola I; Brunetti M; Traynor BJ; Restagno G;
    Neurology; 2012 Nov; 79(19):1983-9. PubMed ID: 23100398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving the knowledge of amyotrophic lateral sclerosis genetics: novel SOD1 and FUS variants.
    Bertolin C; D'Ascenzo C; Querin G; Gaiani A; Boaretto F; Salvoro C; Vazza G; Angelini C; Cagnin A; Pegoraro E; Sorarù G; Mostacciuolo ML
    Neurobiol Aging; 2014 May; 35(5):1212.e7-1212.e10. PubMed ID: 24325798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progranulin does not affect motor neuron degeneration in mutant SOD1 mice and rats.
    Herdewyn S; De Muynck L; Van Den Bosch L; Robberecht W; Van Damme P
    Neurobiol Aging; 2013 Oct; 34(10):2302-3. PubMed ID: 23608112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics of amyotrophic lateral sclerosis: A review.
    Mathis S; Goizet C; Soulages A; Vallat JM; Masson GL
    J Neurol Sci; 2019 Apr; 399():217-226. PubMed ID: 30870681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers.
    Freischmidt A; Müller K; Zondler L; Weydt P; Volk AE; Božič AL; Walter M; Bonin M; Mayer B; von Arnim CA; Otto M; Dieterich C; Holzmann K; Andersen PM; Ludolph AC; Danzer KM; Weishaupt JH
    Brain; 2014 Nov; 137(Pt 11):2938-50. PubMed ID: 25193138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.